Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Eculizumab
Related studies linked through entity extraction aliases.
Eculizumab in Primary MPGN
- Status
- COMPLETED
- Phase
- PHASE2
Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
- Status
- UNKNOWN
- Phase
- PHASE2
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
- Status
- COMPLETED
- Phase
- PHASE3
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
- Status
- COMPLETED
- Phase
- PHASE3
Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
- Status
- TERMINATED
- Phase
- PHASE3
The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
- Status
- COMPLETED
- Phase
- PHASE2
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Study of the Effects of Eculizumab in CD59 Deficiency
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
- Status
- TERMINATED
- Phase
- PHASE2
Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Therapy of Chronic Cold Agglutinin Disease With Eculizumab
- Status
- COMPLETED
- Phase
- PHASE2
Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2